Serum total hCGβ level is an independent prognostic factor in transitional cell carcinoma of the urothelial tract

被引:0
|
作者
J Douglas
A Sharp
C Chau
J Head
T Drake
M Wheater
T Geldart
G Mead
S J Crabb
机构
[1] Cancer Sciences Unit,Department of Urology
[2] University of Southampton Faculty of Medicine,Department of Medical Oncology
[3] Southampton General Hospital,undefined
[4] University Hospital Southampton NHS Foundation Trust,undefined
[5] Southampton General Hospital,undefined
[6] University Hospital Southampton NHS Foundation Trust,undefined
[7] Southampton General Hospital,undefined
[8] NIHR Wellcome Trust Clinical Research Facility,undefined
[9] University of Southampton,undefined
[10] Dorset Cancer Centre,undefined
[11] Poole Hospital NHS Foundation Trust,undefined
来源
British Journal of Cancer | 2014年 / 110卷
关键词
hCG; chemotherapy; cystectomy; prognosis; transitional cell carcinoma; urothelial carcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1759 / 1766
页数:7
相关论文
共 50 条
  • [21] Sarcomatoid urothelial carcinoma accompanied by elevated serum β-HCG: Two case reports Sarcomatoid urothelial carcinoma with elevated serum β-HCG
    Davarci, Sena Ece
    Demir, Hacer
    Demirbas, Arif
    Yalcin, Gulsum Seyma
    Ozdemir, Cigdem
    Ozgul, Esra
    Baykara, Meltem
    [J]. ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2023, 14
  • [23] S-phase - an independent prognostic marker in upper tract urothelial carcinoma
    Malm, Camilla
    Jaremko, Georg
    Brehmer, Marianne
    [J]. SCANDINAVIAN JOURNAL OF UROLOGY, 2022, 56 (5-6) : 397 - 403
  • [24] Serum-sodium as an independent prognostic factor in metastatic renal cell carcinoma
    Jeppesen, A. N.
    Jensen, H. K.
    Donskov, F.
    Marcussen, N.
    von der Maase, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] ELEVATED BLOOD CALCIUM LEVEL AS AN INDEPENDENT PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA
    Bernhard, J. C.
    Crepel, M.
    Verhoest, G.
    Bensalah, K.
    Tostain, J.
    Patard, J. J.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 121 - 121
  • [26] Exploring sequenced chemotherapy regimens in the treatment of transitional cell carcinoma of the urothelial tract
    Bajorin, D. F.
    [J]. EUROPEAN JOURNAL OF CANCER, 2000, 36 : S26 - S29
  • [27] UPPER TRACT UROTHELIAL CELL CARCINOMA LOCATION AS A PREDICTIVE FACTOR FOR CONCOMITANT BLADDER UROTHELIAL CARCINOMA
    Cosentino, M.
    Palou, J.
    Gaya, J. M.
    Breda, A.
    Rodriguez-Fava, O.
    Villavicencio, H.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 100 - 100
  • [28] Independent predictors of metachronous bladder transitional cell carcinoma after nephroureterectomy for transitional cell carcinoma of the upper urinary tract
    Novara, G.
    De Marco, V.
    Dalpiaz, O.
    Bouygues, V.
    Galfano, A.
    Martignoni, G.
    Patand, J. J.
    Artibani, W.
    Ficarra, V.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 136 - 136
  • [29] PREOPERATIVE SYSTEMIC INFLAMMATORY MARKERS IN UPPER TRACT UROTHELIAL CELL CARCINOMA: WHICH IS BETTER AS A PROGNOSTIC FACTOR?
    Hwang, Eu Chang
    Cho, Yang Hyun
    Chung, Ho Seok
    Jung, Seung Il
    Kang, Taek Won
    Kwon, Dong Deuk
    Kim, Myung Ki
    Kang, Sung Gu
    Kang, Seok Ho
    Cheon, Jun
    Ku, Ja Yoon
    Ha, Hong Koo
    Jeong, Chang Wook
    Ku, Ja Hyeon
    Kwak, Cheol
    Kwon, Tae Gyun
    Kim, Tae-Hwan
    Choi, Seock Hwan
    Seo, Ill Young
    [J]. JOURNAL OF UROLOGY, 2017, 197 (04): : E874 - E874
  • [30] Prognostic factors of primary transitional cell carcinoma of the upper urinary tract
    Lee, SH
    Lin, JSN
    Tzai, TS
    Chow, NH
    Tong, YC
    Yang, WH
    Chang, CC
    Cheng, HL
    [J]. EUROPEAN UROLOGY, 1996, 29 (03) : 266 - 270